Dominic Borkelmans is the founder and editor-in-chief of Neurofounders. His work focuses on early-stage companies, clinical and regulatory developments, and the translation of neuroscience into real-world applications. Alongside his editorial work, he is completing an MSc in Applied Neuroscience at King’s College London and collaborates with companies and researchers across the neurotech space.